DNA vaccine manufacture: scale and quality

References

• Wolff JA, Malone RW, Williams P et al. Direct gene transfer into mouse muscle in vivo. Science247(4949 Pt 1), 1465–1468 (1990).
   PubMed Web of Science ®Google Scholar
• Martin JE, Pierson TC, Hubka S et al. A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a Phase 1 clinical trial. J. Infect. Dis.196(12), 1732–1740 (2007).
   PubMed Web of Science ®Google Scholar
• Traxler GS, Anderson E, LaPatra SE, Richard J, Shewmaker B, Kurath G. Naked DNA vaccination of Atlantic salmon Salmo salar against IHNV. Dis. Aquat. Organ.38(3), 183–190 (1999).
   PubMed Web of Science ®Google Scholar
• Bergman PJ, Camps-Palau MA, McKnight JA et al. Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Vaccine24(21), 4582–4585 (2006).
   PubMed Web of Science ®Google Scholar
• Person R, Bodles-Brakhop AM, Pope MA, Brown PA, Khan AS, Draghia-Akli R. Growth hormone-releasing hormone plasmid treatment by electroporation decreases offspring mortality over three pregnancies. Mol. Ther.16(11), 1891–1897 (2008).
   PubMed Web of Science ®Google Scholar
• Herman F. Clinical application of gene transfer. J. Mol. Med.74, 213–221 (1996).
   Google Scholar
• Carnes AE, Williams JA. Plasmid DNA manufacturing technology. Recent Pat. Biotechnol.1(2), 151–166 (2007).
   PubMedGoogle Scholar
• Bazzani RP, Pringle IA, Schleef M et al. The effect of pDNA quality on gene transfer outcome in vivo. Presented at: 12th Annual Meeting of the American Society of Gene Therapy. San Diego, CA, USA, 27–30 May 2009.
   Google Scholar
• Ferreira GN, Cabral JM, Prazeres DM. Development of process flow sheets for the purification of supercoiled plasmids for gene therapy applications. Biotechnol. Prog.15(4), 725–731 (1999).
   PubMed Web of Science ®Google Scholar
• Hirao LA, Draghia-Akli R, Prigge JT et al. High concentration multivalent DNA vaccine for smallpox delivered by intradermic electroporation protects nonhuman primates from Monkeypox challenge. Vaccine (2009) (Epub ahead of print).
   Google Scholar
• Vilalta A, Jimenez G, Rusalov D et al. Vaccination with polymerase chain reaction-generated linear expression cassettes protects mice against lethal influenza A challenge. Hum. Gene Ther.18(8), 763–771 (2007).
   PubMed Web of Science ®Google Scholar
• Lu B, Makhija SK, Nettelbeck DM et al. Evaluation of tumor-specific promoter activities in melanoma. Gene Ther.12(4), 330–338 (2005).
   PubMed Web of Science ®Google Scholar
• Abdulhaqq SA, Weiner DB. DNA vaccines: developing new strategies to enhance immune responses. Immunol. Res.42(1–3), 219–232 (2008).
   PubMed Web of Science ®Google Scholar
• Zakhartchouk AN, Viswanathan S, Moshynskyy I, Petric M, Babiuk LA. Optimization of a DNA vaccine against SARS. DNA Cell Biol.26(10), 721–726 (2007).
   PubMed Web of Science ®Google Scholar
• Coban C, Ishii KJ, Gursel M, Klinman DM, Kumar N. Effect of plasmid backbone modification by different human CpG motifs on the immunogenicity of DNA vaccine vectors. J. Leukoc. Biol.78(3), 647–655 (2005).
   PubMed Web of Science ®Google Scholar
• Hyde SC, Pringle IA, Abdullah S et al. CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression. Nat. Biotechnol.26(5), 549–551 (2008).
   PubMed Web of Science ®Google Scholar
• Soubrier F, Cameron B, Manse B et al. pCOR: a new design of plasmid vectors for nonviral gene therapy. Gene Ther.6(8), 1482–1488 (1999).
   PubMed Web of Science ®Google Scholar
• Williams JA, Carnes AE, Hodgson CP. Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production. Biotechnol. Adv.27(4), 353–370 (2009).
   PubMed Web of Science ®Google Scholar
• Bower DM, Prather KL. Engineering of bacterial strains and vectors for the production of plasmid DNA. Appl. Microbiol. Biotechnol.82(5), 805–813 (2009).
   PubMed Web of Science ®Google Scholar
• Yau SY, Keshavarz-Moore E, Ward J. Host strain influences on supercoiled plasmid DNA production in Escherichia coli: implications for efficient design of large-scale processes. Biotechnol. Bioeng.101(3), 529–544 (2008).
   PubMedGoogle Scholar
• Hebel HL, Cai Y, Davies LA, Hyde SC, Pringle IA, Gill DR. Challenges in the process development of a novel zero-CpG CFTR plasmid for human clinical use. Presented at: 11th Meeting of the American Society of Gene Therapy. Boston, MA, USA, 28 May–1 June 2009.
   Google Scholar
• Phue JN, Lee SJ, Trinh L, Shiloach J. Modified Escherichia coli B (BL21), a superior producer of plasmid DNA compared with Escherichia coli K (DH5α). Biotechnol. Bioeng.101(4), 831–836 (2008).
   PubMed Web of Science ®Google Scholar
• Cranenburgh RM, Hanak JA, Williams SG, Sherratt DJ. Escherichia coli strains that allow antibiotic-free plasmid selection and maintenance by repressor titration. Nucleic Acids Res.29(5), E26 (2001).
   PubMed Web of Science ®Google Scholar
• Dryselius R, Nekhotiaeva N, Nielsen PE, Good L. Antibiotic-free bacterial strain selection using antisense peptide nucleic acid. Biotechniques35(5), 1060–1064 (2003).
   PubMed Web of Science ®Google Scholar
• Szpirer CY, Milinkovitch MC. Separate-component-stabilization system for protein and DNA production without the use of antibiotics. Biotechniques38(5), 775–781 (2005).
   PubMed Web of Science ®Google Scholar
• Carnes AE, Hodgson CP, Williams JA. Inducible Escherichia coli fermentation for increased plasmid DNA production. Biotechnol. Appl. Biochem.45(Pt 3), 155–166 (2006).
   PubMed Web of Science ®Google Scholar
• Danquah MK, Forde GM. Growth medium selection and its economic impact on plasmid DNA production. J. Biosci. Bioeng.104(6), 490–497 (2007).
   Google Scholar
• O’Kennedy RD, Baldwin C, Keshavarz-Moore E. Effects of growth medium selection on plasmid DNA production and initial processing steps. J. Biotechnol.76(2–3), 175–183 (2000).
   PubMedGoogle Scholar
• Williams JA, Luke J, Langtry S, Anderson S, Hodgson CP, Carnes AE. Generic plasmid DNA production platform incorporating low metabolic burden seed-stock and fed-batch fermentation processes. Biotechnol. Bioeng.103(6), 1129–1143 (2009).
   PubMed Web of Science ®Google Scholar
• Meacle FJ, Lander R, Ayazi SP, Titchener-Hooker NJ. Impact of engineering flow conditions on plasmid DNA yield and purity in chemical cell lysis operations. Biotechnol. Bioeng.87(3), 293–302 (2004).
   PubMed Web of Science ®Google Scholar
• Ciccolini LA, Shamlou PA, Titchener-Hooker NJ, Ward JM, Dunnill P. Time course of SDS-alkaline lysis of recombinant bacterial cells for plasmid release. Biotechnol. Bioeng.60(6), 768–770 (1998).
   Google Scholar
• Hebel H, Attra H, Khan A, Draghia-Akli R. Successful parallel development and integration of a plasmid-based biologic, container/closure system and electrokinetic delivery device. Vaccine24(21), 4607–4614 (2006).
   PubMed Web of Science ®Google Scholar
• Machesky L. Plasmid preparations with diatomaceous earth. Methods Mol. Biol.58, 269–272 (1996).
   Google Scholar
• Theodossiou I, Sondergaard M, Thomas OR. Design of expanded bed supports for the recovery of plasmid DNA by anion exchange adsorption. Bioseparation10(1–3), 31–44 (2001).
   PubMedGoogle Scholar
• Eon-Duval A, Gumbs K, Ellett C. Precipitation of RNA impurities with high salt in a plasmid DNA purification process: use of experimental design to determine reaction conditions. Biotechnol. Bioeng.83(5), 544–553 (2003).
   PubMed Web of Science ®Google Scholar
• Eon-Duval A, MacDuff RH, Fisher CA, Harris MJ, Brook C. Removal of RNA impurities by tangential flow filtration in an RNase-free plasmid DNA purification process. Anal. Biochem.316(1), 66–73 (2003).
   PubMed Web of Science ®Google Scholar
• Horn NA, Meek JA, Budahazi G, Marquet M. Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials. Hum. Gene Ther.6(5), 565–573 (1995).
   PubMed Web of Science ®Google Scholar
• Przybylowski M, Bartido S, Borquez-Ojeda O, Sadelain M, Riviere I. Production of clinical-grade plasmid DNA for human Phase I clinical trials and large animal clinical studies. Vaccine25(27), 5013–5024 (2007).
   PubMed Web of Science ®Google Scholar
• Lemmens R, Olsson U, Nyhammar T, Stadler J. Supercoiled plasmid DNA: selective purification by thiophilic/aromatic adsorption. J. Chromatogr. B Analyt.Technol. Biomed. Life Sci.784(2), 291–300 (2003).
   PubMed Web of Science ®Google Scholar
• Varley DL, Hitchcock AG, Weiss AM et al. Production of plasmid DNA for human gene therapy using modified alkaline cell lysis and expanded bed anion exchange chromatography. Bioseparation8(1–5), 209–217 (1999).
   PubMedGoogle Scholar
• Cano T, Murphy JC, Fox GE, Willson RC. Separation of genomic DNA from plasmid DNA by selective renaturation with immobilized metal affinity capture. Biotechnol. Prog.21(5), 1472–1477 (2005).
   PubMedGoogle Scholar
• Costioli MD, Fisch I, Garret-Flaudy F, Hilbrig F, Freitag R. DNA purification by triple-helix affinity precipitation. Biotechnol. Bioeng.81(5), 535–545 (2003).
   PubMed Web of Science ®Google Scholar
• Sousa F, Freitas S, Azzoni AR, Prazeres DM, Queiroz J. Selective purification of supercoiled plasmid DNA from clarified cell lysates with a single histidine-agarose chromatography step. Biotechnol. Appl. Biochem.45(Pt 3), 131–140 (2006).
   PubMedGoogle Scholar
• Darby RA, Forde GM, Slater NK, Hine AV. Affinity purification of plasmid DNA directly from crude bacterial cell lysates. Biotechnol. Bioeng.98(5), 1103–1108 (2007).
   PubMedGoogle Scholar
• Frerix A, Geilenkirchen P, Muller M, Kula MR, Hubbuch J. Separation of genomic DNA, RNA, and open circular plasmid DNA from supercoiled plasmid DNA by combining denaturation, selective renaturation and aqueous two-phase extraction. Biotechnol. Bioeng.96(1), 57–66 (2007).
   Google Scholar
• Frerix A, Muller M, Kula MR, Hubbuch J. Scalable recovery of plasmid DNA based on aqueous two-phase separation. Biotechnol. Appl. Biochem.42(Pt 1), 57–66 (2005).
   Google Scholar
• Urthaler J, Buchinger W, Necina R. Improved downstream process for the production of plasmid DNA for gene therapy. Acta Biochim. Pol.52(3), 703–711 (2005).
   PubMed Web of Science ®Google Scholar
• Laddy DJ, Yan J, Khan AS et al. Electroporation of synthetic DNA antigens offers protection in non-human primates challenged with highly pathogenic avian influenza. J. Virol.83(9), 4624–4630 (2009).
   PubMed Web of Science ®Google Scholar
• Laddy DJ, Yan J, Kutzler M et al. Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens. PLoS ONE3(6), e2517 (2008).
   PubMed Web of Science ®Google Scholar
• Yan J, Harris K, Khan AS, Draghia-Akli R, Sewell DA, Weiner DB. Cellular immunity induced by a novel HPV18 DNA vaccine encoding an E6/E7 fusion consensus protein in mice and rhesus macaques. Vaccine26(40), 5210–5215 (2008).
   PubMed Web of Science ®Google Scholar
• Quaak SG, van den Berg JH, Toebes M et al. GMP production of pDERMATT for vaccination against melanoma in a Phase I clinical trial. Eur. J. Pharm. Biopharm.70, 429–438 (2008).
   PubMed Web of Science ®Google Scholar
• Kong S, Rock CF, Booth A et al. Large-scale plasmid DNA processing: evidence that cell harvesting and storage methods affect yield of supercoiled plasmid DNA. Biotechnol. Appl. Biochem.51(Pt 1), 43–51 (2008).
   PubMed Web of Science ®Google Scholar
• Zhang S, Krivosheyeva A, Nochumson S. Large-scale capture and partial purification of plasmid DNA using anion-exchange membrane capsules. Biotechnol. Appl. Biochem.37(Pt 3), 245–249 (2003).
   PubMed Web of Science ®Google Scholar
• Guerrero-German P, Prazeres DM, Guzman R, Montesinos-Cisneros RM, Tejeda-Mansir A. Purification of plasmid DNA using tangential flow filtration and tandem anion-exchange membrane chromatography. Bioprocess Biosyst. Eng.32(5), 615–623 (2008).
   Google Scholar
• Schorr J, Moritz P, Breul A, Scheef M. Production of plasmid DNA in industrial quantities according to cGMP guidelines. Methods Mol. Med.127, 339–350 (2006).
   Google Scholar
• Murphy JC, Cano T, Fox GE, Willson RC. Compaction agent protection of nucleic acids during mechanical lysis. Biotechnol. Prog.22(2), 519–522 (2006).
   Google Scholar
• Carnes AE, Hodgson CP, Luke JM, Vincent JM, Williams JA. Plasmid DNA production combining antibiotic-free selection, inducible high yield fermentation, and novel autolytic purification. Biotechnol. Bioeng. (2009) (Epub ahead of print).
   Google Scholar
• Berrill A, Ho SV, Bracewell DG. Ultra scale-down to define and improve the relationship between flocculation and disc-stack centrifugation. Biotechnol. Prog.24(2), 426–431 (2008).
   Google Scholar
• Kendall D, Lye GJ, Levy MS. Purification of plasmid DNA by an integrated operation comprising tangential flow filtration and nitrocellulose adsorption. Biotechnol. Bioeng.79(7), 816–822 (2002).
   Google Scholar
• Azevedo AM, Rosa PA, Ferreira IF, Aires-Barros MR. Chromatography-free recovery of biopharmaceuticals through aqueous two-phase processing. Trends Biotechnol.27(4), 240–247 (2009).
   PubMed Web of Science ®Google Scholar
• Trindade IP, Diogo MM, Prazeres DM, Marcos JC. Purification of plasmid DNA vectors by aqueous two-phase extraction and hydrophobic interaction chromatography. J. Chromatogr. A1082(2), 176–184 (2005).
   PubMed Web of Science ®Google Scholar
• Freitas S, Canario S, Santos JA, Prazeres DM. Alternatives for the intermediate recovery of plasmid DNA: performance, economic viability and environmental impact. Biotechnol. J.4(2), 265–278 (2009).
   PubMedGoogle Scholar
• Ferreira GNM. Chromatographic approaches in the purification of plasmid DNA for therapy and vaccination. Chem.Engin. Technol.28(11), 1285–1294 (2005).
   Web of Science ®Google Scholar
• Sandberg LM, Bjurling A, Busson P, Vasi J, Lemmens R. Thiophilic interaction chromatography for supercoiled plasmid DNA purification. J. Biotechnol.109(1–2), 193–199 (2004).
   Google Scholar
• Urthaler J, Schlegl R, Podgornik A, Strancar A, Jungbauer A, Necina R. Application of monoliths for plasmid DNA purification development and transfer to production. J. Chromatogr. A1065(1), 93–106 (2005).
   PubMed Web of Science ®Google Scholar
• Danquah MK, Forde GM. Large-volume methacrylate monolith for plasmid purification. Process engineering approach to synthesis and application. J. Chromatogr. A1188(2), 227–233 (2008).
   Google Scholar
• Danquah MK, Forde GM. Enhancing methacrylate-monolith-based downstream processes to champion plasmid DNA production. Biotechnol. Appl. Biochem.48(Pt 2), 85–91 (2007).
   Google Scholar
• Lander RJ, Winters MA, Meacle FJ, Buckland BC, Lee AL. Fractional precipitation of plasmid DNA from lysate by CTAB. Biotechnol. Bioeng.79(7), 776–784 (2002).
   PubMed Web of Science ®Google Scholar
• Sauer ML, Kollars B, Geraets R, Sutton F. Sequential CaCl2, polyethylene glycol precipitation for RNase-free plasmid DNA isolation. Anal. Biochem.380(2), 310–314 (2008).
   Google Scholar